Inventor · disambiguated record
Yunxiao Li
Also filed as: LI YUNXIAO
28 granted patents·9 pending applications·279 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
37 records- 0197US10300075B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted May 28, 2019·22 cites·39 claims
- 0297US9562061B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2015·Granted Feb 7, 2017·39 cites·30 claims
- 0396US7351740B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2006·Granted Apr 1, 2008·43 cites·48 claims
- 0494US6518364B2Emulsion living-type free radical polymerization, methods and products of sameSYMYX TECHNOLOGIES INC·Filed 2001·Granted Feb 11, 2003·57 cites·24 claims
- 0593US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 0693US7994218B2Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useXENOPORT INC·Filed 2008·Granted Aug 9, 2011·14 cites·21 claims
- 0791US11273743B1Mat mounting structure in seat back and vehicle seatADIENT ENG & IP GMBH·Filed 2020·Granted Mar 15, 2022·6 cites·2 claims
- 0891US10500213B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Dec 10, 2019·6 cites·46 claims
- 0991US10100063B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2016·Granted Oct 16, 2018·8 cites·12 claims
- 1090US8168617B2Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Granted May 1, 2012·24 cites·25 claims
- 1189US7592369B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2007·Granted Sep 22, 2009·10 cites·44 claims
- 1281USD1066955SAir bedLI YUNXIAO·Filed 2023·Granted Mar 18, 2025·6 cites·1 claims
- 1381US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1478US6559255B2Controlled free radical emulsion and water-based polymerizations and seeded methodologiesSYMYX TECHNOLOGIES INC·Filed 2000·Granted May 6, 2003·15 cites·4 claims
- 1576US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 1675USD1072528SAir bedLI YUNXIAO·Filed 2023·Granted Apr 29, 2025·4 cites·1 claims
- 1775US7777070B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2009·Granted Aug 17, 2010·1 cites·34 claims
- 1874USD1065877SAir bedLI YUNXIAO·Filed 2023·Granted Mar 11, 2025·4 cites·1 claims
- 1974US10836779B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Nov 17, 2020·0 cites·8 claims
- 2072US11993183B2Seat slide deviceADIENT US LLC·Filed 2021·Granted May 28, 2024·1 cites·2 claims
- 2172US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 2271USD1069461SAir bedLI YUNXIAO·Filed 2023·Granted Apr 8, 2025·3 cites·1 claims
- 2369US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 2469US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 2566US6518448B2Compounds useful for control agents for living-type free radical polymerizationSYMYX TECHNOLOGIES INC·Filed 2001·Granted Feb 11, 2003·5 cites·4 claims
- 2658US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2757US6841624B2Control agents for living-type free radical polymerization, methods of polymerizing and polymers with sameSYMYX TECHNOLOGIES INC·Filed 2003·Granted Jan 11, 2005·2 cites·25 claims
- 2856US8372881B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2010·Granted Feb 12, 2013·0 cites·23 claims
- 2956US6482909B2Compounds useful for control agents for living-type free radical polymerizationSYMYX TECHNOLOGIES INC·Filed 2001·Granted Nov 19, 2002·2 cites·4 claims
- 3055US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3155US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3254US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3354US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3454US2009099253A1Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of UseXENOPORT INC·Filed 2008·Application pending·0 cites
- 3549US11364248B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2018·Granted Jun 21, 2022·0 cites·45 claims
- 3648US11279712B2Macrocyclic compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Mar 22, 2022·0 cites·21 claims
- 3747US2009082464A1Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yunxiao Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →